Avian influenza: genetic evolution under vaccination pressure
© Escorcia et al. 2008
Received: 05 December 2007
Accepted: 24 January 2008
Published: 24 January 2008
Antigenic drift of avian influenza viruses (AIVs) has been observed in chickens after extended vaccination program, similar to those observed with human influenza viruses. To evaluate the evolutionary properties of endemic AIV under high vaccination pressure (around 2 billion doses used in the last 12 years), we performed a pilot phylogenic analysis of the hemagglutinin (HA) gene of AIVs isolated from 1994 to 2006. This study demonstrates that Mexican low pathogenicity (LP) H5N2-AIVs are constantly undergoing genetic drifts. Recent AIV isolates (2002–2006) show significant molecular drifts when compared with the H5N2 vaccine-strain or other field isolates (1994–2000). This study also demonstrates that molecular drifts in the HA gene lineages follow a yearly trend, suggesting gradually cumulative sequence mutations. These findings might explain the increasing incidence of LP H5N2 AIV isolated from commercial avian farms. These findings support recent concerns about the challenge of AIV antigenic drift and influenza epidemics.
Avian influenza virus
Mexican Ministry of Agriculture, Livestock Rural Development, Fisheries and Food
Phylogenetic Analysis Using Parsimony
Reverse transcriptase polymerase chain reaction
Avian influenza virus (AIV) is a member of theOrthomyxoviridae family,Influenzavirus A genus. AIV is characterized by its ability to undergo constant antigenic changes . AIV envelope contains two major glycoproteins, hemagglutinin (HA) and neuraminidase (NA) . The HA/NA proteins play a key role during cellular infection. Different HA/NA combinations allow AIV subtype discrimination. Depending on the damage caused to avian species, AIVs are categorized as either high or low pathogenicity (HP and LP, respectively).
In Mexico, LP AIV was first detected in May 1994, among commercial farms. Since then, an Avian Influenza National Campaign established by the Mexican Ministry of Agriculture, Livestock, Rural Development, Fisheries and Food (SAGARPA, its Spanish acronym), is in operation. The purpose of this campaign is to eradicate the subtype H5N2 LP AIV that is still present in specific areas of Mexico. Vaccination of commercial flocks is one of many strategies for this campaign. The vaccine strain officially authorized, as seed for commercial vaccine production is the A/Ck/México/CPA-232/94 (H5N2), isolated in 1994 .
The use of the commercial vaccine in Mexico was originally aimed to eradicate HP AIV and this was accomplished in June 1994. Then, the decision was made to continue vaccinating in order to protect commercial flocks from LP AIV outbreaks. Nevertheless, 13 years after the use of the vaccination started and more than 2 billion doses were used in the Mexican avian industry , an increase in respiratory signs of disease has been observed in vaccinated, field challenged birds.
The current increase in incidence of AIV infection is most likely related to antigenic drifts occurred in field AIV strains . Moreover, veterinary services revealed more than two log differences in cross hemagglutination inhibition tests between field isolates and the vaccine seed virus (Lucio E., unpublished).
Vaccination programs produce faster antigenic drifts of human and avian influenza viruses . Nevertheless, there are few biological systems to explore the dynamic of influenza virus evolution. In the present study, we explored the use of the Mexican aviculture as an example of a suitable model to evaluate the evolutionary properties of endemic AIV under high vaccination pressure. The Mexican aviculture system offers an excellent model to study AIV genetic evolution under high vaccination pressure for two important grounds: i) avian influenza vaccination is a regular veterinary practice, and ii) poultry systems are characterized by high avian population density per production unit. We compared HA gene sequences from AIVs isolated between 1994 and 2000 , more recent isolates (2002 to 2006) from vaccinated birds showing clinical manifestations of avian influenza, and the A/Chicken/Hidalgo/232/94 vaccine strain.
For the present study, we used the complete collection of eighteen AIV strains isolated from years 2002 to 2006 from nine different regions of Mexico. These strains were isolated and guarded by an officially certified laboratory to issue reports for control and eradication of avian influenza in Mexico. All AIVs were obtained from vaccinated birds showing clinical signs of avian influenza. Viral RNA extraction from allantoic fluid was performed using conventional methods . Reverse transcriptase PCR (RT-PCR) was used for the amplification of the HA cleavage site sequence, a marker for the virulence potential of avian influenza viruses . Sequencing of the HA gene segments was performed using the 3730Xl automated sequencer (Applied Biosystems, CA. USA). The nucleotide sequences obtained in this study (available from the authors upon request) and sequences retrieved from the GenBank database under accession numbers [GenBank:AY497063 to AY497096] produced from Mexican AIVs  were analyzed by using the CLUSTALW package and then edited using the jalview program . Because the sequences retrieved from GenBank differed in extension, the flanking N-term and C-term regions were removed for the alignment. Edited sequences were re-aligned using the ClustalX 1.81 program  with the following parameters. Pair-wise: gap opening = 10.0, gap extension = 0.10; Alignment: gap opening = 10.0, gap extension = 0.2, and Gonnet series weight matrix. Phylogenetic trees were constructed with the Maximum Parsimony method  using the PAUP* 4.0 b10 program . Trees were rooted using [GenBank:AY497063] (vaccine strain) as ancestral nucleotide sequence. The statistical significance of branch order was estimated by the generation of 1000 replications of bootstrap re-sampling of the originally-aligned nucleotide sequences.
Conversely, the construction of phylogenetic trees with the HA sequences from 1994–2002 isolates and from 2002–2006 isolates (present study) show that the HA sequences are grouped in four (I-IV) lineages. Likewise, these 4 viral Mexican AIV lineages follow an isolation year trend (Figures 1C–D). Same lineages were obtained when unrooted phylogenetic trees were constructed (not shown). These four lineages include sequences previously classified as Jalisco, A, and B . Since 2004, no other additional studies have evaluated the evolution of LP AIVs circulating in Mexico. In here, we provide evidence of the currently existing Mexican AIV lineages.
Mexico has been world's first country in adopting vaccination of commercial poultry as one of several measures for avian influenza control and eradication. Since 1995, more than 2 billion vaccine doses have been used in the Mexican avian industry .
Results from the present study show that recent Mexican LP H5N2 AIV field isolates show constant drifts in their genetic information. The phylogenetic analysis shows that all eighteen recent isolates (2002–2006) have undergone important drifts in the HA gene sequence as compared with vaccine strain. This finding indicates that it is important to consider new prophylactic strategies against avian influenza in Mexico as well as in other countries which are currently using the same vaccine. Swayneet al. (2000) reported that the percent homology of the HA gene sequence between field isolates and the vaccine strain is essential to decrease spread levels of field AIV strains . The genomic variation found in the present study might explain the permanence of LP AIV in Mexico since 1994, despite the use of both vaccination and stringent biosecurity measures .
In previous reports, homology in HA sequences of AIVs isolated between 1994–2002 was 86.0–99.8% . Comparable homology values (86.8–99.0%) were estimated in the present study within the 2002–2006 AIV isolates. Sequences from recent (2002–2006) AIV isolates and the vaccine strain show significant phylogenetic divergence. This could explain the clinical signs observed in the vaccinated chickens.
It is possible that avian influenza vaccination has resulted in accelerated genetic drifts in the HA gene sequence, as previously suggested by Leeet al. (2004). However, Ellis and Zambon (2001), Gambaryanet al. (2006), Widjajaet al. (2006) showed that viral replicationper se allows for the expression of drifts among subsequent viral populations [14–16].
The AIVs sequences obtained in the present study are closely related to lineage B reported by Leeet al. (2004), which are viruses phylogenetically more distant from the vaccine strain . Therefore, it is important to implement more rigorous requisites than those proposed by the World Organization of Animal Health (OIE) which only considered protection afforded by the vaccine in terms of bird survival rates. Together with other measures, protection in terms of reduced viral spread from vaccine strains has also been an indispensable requirement to achieve the goal of eradication.
The present phylogenetic analysis based on the analysis of HA gene shows that cumulative genetic drifts in the HA gene allow distinction between new and old AIV lineages. The occurrence of influenza outbreaks could be associated to antigenic drifts, in which changes in viral antigens provide and evolutionary advantage to re-infect the same host . All these together, support the recent concerns about the challenge of AIV antigenic drift and influenza epidemics.
Finally, we consider that the current biological system (Mexican avian industry) is a suitable model to evaluate the evolutionary properties of endemic AIV under high vaccination pressure. Further studies need to be conducted to compare HA sequences from countries without avian influenza vaccine.
We thank Laura Guest and Karol Carrillo for technical assistance.
- Ito T, Goto H, Yamamoto E, Tanaka H, Takeuchi M, Kuwayama M, Kawaoka Y, Otsuki K: Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol 2001,75:4439–4443.View ArticlePubMed
- Swayne DE, Halvorson DA: Influenza. Diseases of poultry (Edited by: Saif YM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE). Ames Iowa, IA: Iowa State University Press 2003, 135–160.
- Lee CW, Senne DA, Suarez DL: Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004,78:8372–8381.View ArticlePubMed
- Villarreal-Chavez C, Rivera-Cruz E: An update on avian influenza in Mexico. Avian Dis 2003,47:1002–1005.View ArticlePubMed
- Smith DJ, Forrest S, Ackley DH, Perelson AS: Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA 1999,96:14001–14006.View ArticlePubMed
- Suarez DL, Lee CW, Swayne DE: Avian influenza vaccination in North America: strategies and difficulties. Dev Biol (Basel) 2006,124:117–124.
- Perozo F, Villegas P, Estevez C, Alvarado I, Purvis LB: Use of FTA filter paper for the molecular detection of Newcastle disease virus. Avian Pathol 2006,35:93–98.View ArticlePubMed
- Horimoto T, Kawaoka Y: Direct reverse transcriptase PCR to determine virulence potential of influenza A viruses in birds. J Clin Microbiol 1995,33:748–751.PubMed
- CLUSTALW package and the jalview program [http://www.ebi.ac.uk/clustalw/]
- Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997,25:4876–4882.View ArticlePubMed
- Eck RV, Dayhoff MO: Atlas of protein sequence and structure Silver Spring, MD: National Biomedical Research Foundation 1966.
- Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods) Sunderland, MA: Sinauer Associates 2002.
- Swayne DE, Perdue ML, Beck JR, Garcia M, Suarez DL: Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet Microbiol 2000,74:165–172.View ArticlePubMed
- Ellis JS, Zambon MC: Combined PCR-heteroduplex mobility assay for detection and differentiation of influenza A viruses from different animal species. J Clin Microbiol 2001,39:4097–4102.View ArticlePubMed
- Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, Klimov A: Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006,344:432–438.View ArticlePubMed
- Widjaja L, Ilyushina N, Webster RG, Webby RJ: Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 2006,350:137–145.View ArticlePubMed
- Carrat F, Flahault A: Influenza vaccine: The challenge of antigenic drift. Vaccine 2007.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.